{"transactions":[{"id":1304576,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2025-01-13T22:29:23.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":2.44,"value":54900.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to certain restrictions, beginning on this date, options vest in three equal annual installments."}],"balance_after":22500,"derivative":{"exercise_price":2.44,"exercise_date":"2025-12-31","expiration_date":"2031-12-31","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-25-004913","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/883107/000095017025004913/ownership.xml","form_type":"4"}},{"id":1399759,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2024-09-25T20:00:06.000Z","date":"2024-09-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":81000,"price":0.44,"value":35640.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to certain restrictions, beginning on this date, options vest in three equal annual installments."}],"balance_after":0,"derivative":{"exercise_price":0.44,"exercise_date":"2016-02-18","expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0000950170-24-109325","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000095017024109325/ownership.xml","form_type":"4"}},{"id":1399758,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-09-25T20:00:06.000Z","date":"2024-09-24","kind":"exercise","planned":false,"acquired":true,"shares":81000,"price":0.444,"value":35964.0,"ownership":{"direct":true},"balance_after":207450,"source":{"system":"sec-edgar","filing":"0000950170-24-109325","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883107/000095017024109325/ownership.xml","form_type":"4"}},{"id":1647441,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-02-13T21:00:15.000Z","date":"2024-02-08","kind":"purchase","planned":false,"acquired":true,"shares":7008,"price":0.4,"value":2803.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased as part of the Company's recent shareholder rights offering."}],"balance_after":133458,"source":{"system":"sec-edgar","filing":"0001209191-24-003167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919124003167/doc4.xml","form_type":"4"}},{"id":1673541,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2024-01-23T11:00:07.000Z","date":"2024-01-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":67450,"price":0.52,"value":35074.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments."}],"balance_after":0,"derivative":{"exercise_price":0.52,"exercise_date":"2015-02-13","expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":67450},"source":{"system":"sec-edgar","filing":"0001209191-24-002024","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919124002024/doc4.xml","form_type":"4"}},{"id":1673540,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-01-23T11:00:07.000Z","date":"2024-01-19","kind":"exercise","planned":false,"acquired":true,"shares":67450,"price":0.52,"value":35074.0,"ownership":{"direct":true},"balance_after":126450,"source":{"system":"sec-edgar","filing":"0001209191-24-002024","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919124002024/doc4.xml","form_type":"4"}},{"id":1698237,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2023-12-29T21:00:12.000Z","date":"2023-12-27","kind":"grant","planned":false,"acquired":true,"shares":12600,"price":0.61,"value":7686.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments."}],"balance_after":12600,"derivative":{"exercise_price":0.61,"exercise_date":"2024-12-27","expiration_date":"2030-12-27","underlying":"Common Stock","underlying_shares":12600},"source":{"system":"sec-edgar","filing":"0001209191-23-059982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123059982/doc4.xml","form_type":"4"}},{"id":1785185,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2023-09-09T00:00:07.000Z","date":"2023-09-08","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These stock options are set to expire on 02/13/2024.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments."}],"balance_after":67450,"derivative":{"exercise_price":0.52,"exercise_date":"2015-02-13","expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":69950},"source":{"system":"sec-edgar","filing":"0001209191-23-048852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048852/doc4.xml","form_type":"4"}},{"id":1785184,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2023-09-09T00:00:07.000Z","date":"2023-09-07","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These stock options are set to expire on 02/13/2024.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to certain restrictions, beginning on this date, options vest in three equal installments."}],"balance_after":69950,"derivative":{"exercise_price":0.52,"exercise_date":"2015-02-13","expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":72450},"source":{"system":"sec-edgar","filing":"0001209191-23-048852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048852/doc4.xml","form_type":"4"}},{"id":1785183,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2023-09-09T00:00:07.000Z","date":"2023-09-06","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0.52,"value":520.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These stock options are set to expire on 02/13/2024.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to certain restrictions, beginning on this date, options vest in three equal installments."}],"balance_after":72450,"derivative":{"exercise_price":0.52,"exercise_date":"2015-02-13","expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":73450},"source":{"system":"sec-edgar","filing":"0001209191-23-048852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048852/doc4.xml","form_type":"4"}},{"id":1785182,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-09-09T00:00:07.000Z","date":"2023-09-08","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc.  Given the quantity of shares involved relative to daily trading volume, the limited amount of open trading days available due to trading blackout periods, and looming stock option expirations, Mr. Jankowski established a 10b5-1 Plan to avoid the loss of these rights in a way intended to minimize the impact on Nanophase shareholders."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-23-048852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048852/doc4.xml","form_type":"4"}},{"id":1785181,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-09-09T00:00:07.000Z","date":"2023-09-08","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options are set to expire on 02/13/2024. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker to avoid the loss of these stock option rights.  His goal is to have this broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":61500,"source":{"system":"sec-edgar","filing":"0001209191-23-048852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048852/doc4.xml","form_type":"4"}},{"id":1785180,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-09-09T00:00:07.000Z","date":"2023-09-07","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc.  Given the quantity of shares involved relative to daily trading volume, the limited amount of open trading days available due to trading blackout periods, and looming stock option expirations, Mr. Jankowski established a 10b5-1 Plan to avoid the loss of these rights in a way intended to minimize the impact on Nanophase shareholders."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-23-048852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048852/doc4.xml","form_type":"4"}},{"id":1785179,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-09-09T00:00:07.000Z","date":"2023-09-07","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options are set to expire on 02/13/2024. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker to avoid the loss of these stock option rights.  His goal is to have this broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":61500,"source":{"system":"sec-edgar","filing":"0001209191-23-048852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048852/doc4.xml","form_type":"4"}},{"id":1785178,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-09-09T00:00:07.000Z","date":"2023-09-06","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":1,"value":1000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc.  Given the quantity of shares involved relative to daily trading volume, the limited amount of open trading days available due to trading blackout periods, and looming stock option expirations, Mr. Jankowski established a 10b5-1 Plan to avoid the loss of these rights in a way intended to minimize the impact on Nanophase shareholders."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-23-048852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048852/doc4.xml","form_type":"4"}},{"id":1785177,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-09-09T00:00:07.000Z","date":"2023-09-06","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":0.52,"value":520.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options are set to expire on 02/13/2024. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker to avoid the loss of these stock option rights.  His goal is to have this broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001209191-23-048852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048852/doc4.xml","form_type":"4"}},{"id":1789920,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2023-09-06T00:00:08.000Z","date":"2023-09-05","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These stock options are set to expire on 02/13/2024.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments."}],"balance_after":73450,"derivative":{"exercise_price":0.52,"exercise_date":"2015-02-13","expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":75950},"source":{"system":"sec-edgar","filing":"0001209191-23-048252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048252/doc4.xml","form_type":"4"}},{"id":1789919,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2023-09-06T00:00:08.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These stock options are set to expire on 02/13/2024.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to certain restrictions, beginning on this date, options vest in three equal installments."}],"balance_after":75950,"derivative":{"exercise_price":0.52,"exercise_date":"2015-02-13","expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":78450},"source":{"system":"sec-edgar","filing":"0001209191-23-048252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048252/doc4.xml","form_type":"4"}},{"id":1789918,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2023-09-06T00:00:08.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These stock options are set to expire on 02/13/2024.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to certain restrictions, beginning on this date, options vest in three equal installments."}],"balance_after":78450,"derivative":{"exercise_price":0.52,"exercise_date":"2015-02-13","expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":80950},"source":{"system":"sec-edgar","filing":"0001209191-23-048252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048252/doc4.xml","form_type":"4"}},{"id":1789917,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-09-06T00:00:08.000Z","date":"2023-09-05","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":1.014,"value":2535.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc.  Given the quantity of shares involved relative to daily trading volume, the limited amount of open trading days available due to trading blackout periods, and looming stock option expirations, Mr. Jankowski established a 10b5-1 Plan to avoid the loss of these rights in a way intended to minimize the impact on Nanophase shareholders."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-23-048252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048252/doc4.xml","form_type":"4"}},{"id":1789916,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-09-06T00:00:08.000Z","date":"2023-09-05","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options are set to expire on 02/13/2024. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker to avoid the loss of these stock option rights.  His goal is to have this broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":61500,"source":{"system":"sec-edgar","filing":"0001209191-23-048252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048252/doc4.xml","form_type":"4"}},{"id":1789915,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-09-06T00:00:08.000Z","date":"2023-09-01","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc.  Given the quantity of shares involved relative to daily trading volume, the limited amount of open trading days available due to trading blackout periods, and looming stock option expirations, Mr. Jankowski established a 10b5-1 Plan to avoid the loss of these rights in a way intended to minimize the impact on Nanophase shareholders."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-23-048252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048252/doc4.xml","form_type":"4"}},{"id":1789914,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-09-06T00:00:08.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options are set to expire on 02/13/2024. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker to avoid the loss of these stock option rights.  His goal is to have this broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":61500,"source":{"system":"sec-edgar","filing":"0001209191-23-048252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048252/doc4.xml","form_type":"4"}},{"id":1789913,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-09-06T00:00:08.000Z","date":"2023-08-31","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc.  Given the quantity of shares involved relative to daily trading volume, the limited amount of open trading days available due to trading blackout periods, and looming stock option expirations, Mr. Jankowski established a 10b5-1 Plan to avoid the loss of these rights in a way intended to minimize the impact on Nanophase shareholders."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-23-048252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048252/doc4.xml","form_type":"4"}},{"id":1789912,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-09-06T00:00:08.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options are set to expire on 02/13/2024. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker to avoid the loss of these stock option rights.  His goal is to have this broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":61500,"source":{"system":"sec-edgar","filing":"0001209191-23-048252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123048252/doc4.xml","form_type":"4"}},{"id":1792322,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2023-08-31T22:40:03.000Z","date":"2023-08-30","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These stock options are set to expire on 02/13/2024.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to certain restrictions, beginning on this date, options vest in three equal installments."}],"balance_after":80950,"derivative":{"exercise_price":0.52,"exercise_date":"2015-02-13","expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":83450},"source":{"system":"sec-edgar","filing":"0001209191-23-047878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047878/doc4.xml","form_type":"4"}},{"id":1792321,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2023-08-31T22:40:03.000Z","date":"2023-08-29","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These stock options are set to expire on 02/13/2024.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to certain restrictions, beginning on this date, options vest in three equal installments."}],"balance_after":83450,"derivative":{"exercise_price":0.52,"exercise_date":"2015-02-13","expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":85950},"source":{"system":"sec-edgar","filing":"0001209191-23-047878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047878/doc4.xml","form_type":"4"}},{"id":1792320,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-08-31T22:40:03.000Z","date":"2023-08-30","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc.  Given the quantity of shares involved relative to daily trading volume, the limited amount of open trading days available due to trading blackout periods, and looming stock option expirations, Mr. Jankowski established a 10b5-1 Plan to avoid the loss of these rights in a way intended to minimize the impact on Nanophase shareholders."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-23-047878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047878/doc4.xml","form_type":"4"}},{"id":1792319,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-08-31T22:40:03.000Z","date":"2023-08-30","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options are set to expire on 02/13/2024. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker to avoid the loss of these stock option rights.  His goal is to have this broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":61500,"source":{"system":"sec-edgar","filing":"0001209191-23-047878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047878/doc4.xml","form_type":"4"}},{"id":1792318,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-08-31T22:40:03.000Z","date":"2023-08-29","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":1,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc.  Given the quantity of shares involved relative to daily trading volume, the limited amount of open trading days available due to trading blackout periods, and looming stock option expirations, Mr. Jankowski established a 10b5-1 Plan to avoid the loss of these rights in a way intended to minimize the impact on Nanophase shareholders."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-23-047878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047878/doc4.xml","form_type":"4"}},{"id":1792317,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-08-31T22:40:03.000Z","date":"2023-08-29","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options are set to expire on 02/13/2024. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker to avoid the loss of these stock option rights.  His goal is to have this broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":61500,"source":{"system":"sec-edgar","filing":"0001209191-23-047878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047878/doc4.xml","form_type":"4"}},{"id":1795649,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2023-08-29T00:00:09.000Z","date":"2023-08-28","kind":"exercise","planned":false,"acquired":false,"shares":500,"price":0.52,"value":260.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These stock options are set to expire on 02/13/2024.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to certain restrictions, beginning on this date, options vest in three equal installments."}],"balance_after":85950,"derivative":{"exercise_price":0.52,"exercise_date":"2015-02-13","expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":86450},"source":{"system":"sec-edgar","filing":"0001209191-23-047549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047549/doc4.xml","form_type":"4"}},{"id":1795648,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2023-08-29T00:00:09.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":false,"shares":1050,"price":0.52,"value":546.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These stock options are set to expire on 02/13/2024.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to certain restrictions, beginning on this date, options vest in three equal installments."}],"balance_after":86450,"derivative":{"exercise_price":0.52,"exercise_date":"2015-02-13","expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001209191-23-047549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047549/doc4.xml","form_type":"4"}},{"id":1795647,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2023-08-29T00:00:09.000Z","date":"2023-08-24","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These stock options are set to expire on 02/13/2024.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to certain restrictions, beginning on this date, options vest in three equal installments."}],"balance_after":87500,"derivative":{"exercise_price":0.52,"exercise_date":"2015-02-13","expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-23-047549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047549/doc4.xml","form_type":"4"}},{"id":1795646,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-08-29T00:00:09.000Z","date":"2023-08-28","kind":"sale","planned":false,"acquired":false,"shares":500,"price":1,"value":500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc.  Given the quantity of shares involved relative to daily trading volume, the limited amount of open trading days available due to trading blackout periods, and looming stock option expirations, Mr. Jankowski established a 10b5-1 Plan to avoid the loss of these rights in a way intended to minimize the impact on Nanophase shareholders."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-23-047549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047549/doc4.xml","form_type":"4"}},{"id":1795645,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-08-29T00:00:09.000Z","date":"2023-08-28","kind":"exercise","planned":false,"acquired":true,"shares":500,"price":1,"value":500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options are set to expire on 02/13/2024. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker to avoid the loss of these stock option rights.  His goal is to have this broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":59500,"source":{"system":"sec-edgar","filing":"0001209191-23-047549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047549/doc4.xml","form_type":"4"}},{"id":1795644,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-08-29T00:00:09.000Z","date":"2023-08-25","kind":"sale","planned":false,"acquired":false,"shares":1050,"price":1.015,"value":1065.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc.  Given the quantity of shares involved relative to daily trading volume, the limited amount of open trading days available due to trading blackout periods, and looming stock option expirations, Mr. Jankowski established a 10b5-1 Plan to avoid the loss of these rights in a way intended to minimize the impact on Nanophase shareholders."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-23-047549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047549/doc4.xml","form_type":"4"}},{"id":1795643,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-08-29T00:00:09.000Z","date":"2023-08-25","kind":"exercise","planned":false,"acquired":true,"shares":1050,"price":0.52,"value":546.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options are set to expire on 02/13/2024. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker to avoid the loss of these stock option rights.  His goal is to have this broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":60050,"source":{"system":"sec-edgar","filing":"0001209191-23-047549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047549/doc4.xml","form_type":"4"}},{"id":1795642,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-08-29T00:00:09.000Z","date":"2023-08-24","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":1.005,"value":2512.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc.  Given the quantity of shares involved relative to daily trading volume, the limited amount of open trading days available due to trading blackout periods, and looming stock option expirations, Mr. Jankowski established a 10b5-1 Plan to avoid the loss of these rights in a way intended to minimize the impact on Nanophase shareholders."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-23-047549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047549/doc4.xml","form_type":"4"}},{"id":1795641,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-08-29T00:00:09.000Z","date":"2023-08-24","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0.52,"value":1300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options are set to expire on 02/13/2024. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker to avoid the loss of these stock option rights.  His goal is to have this broker sell shares from this grant, under fixed guidelines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":61500,"source":{"system":"sec-edgar","filing":"0001209191-23-047549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919123047549/doc4.xml","form_type":"4"}},{"id":2078154,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-12-22T16:27:16.000Z","date":"2022-12-20","kind":"grant","acquired":true,"shares":72000,"price":1.165,"value":83880.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments."}],"balance_after":72000,"derivative":{"exercise_price":1.165,"exercise_date":"2023-12-20","expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001209191-22-062393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122062393/doc4.xml","form_type":"4"}},{"id":2085683,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-12-16T02:00:28.000Z","date":"2022-12-14","kind":"exercise","acquired":false,"shares":1514,"price":0.415,"value":628.31,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F5","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":4296,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":5810},"source":{"system":"sec-edgar","filing":"0001209191-22-061552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122061552/doc4.xml","form_type":"4"}},{"id":2085682,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-12-16T02:00:28.000Z","date":"2022-12-13","kind":"exercise","acquired":false,"shares":400,"price":0.415,"value":166.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F5","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":5810,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":6210},"source":{"system":"sec-edgar","filing":"0001209191-22-061552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122061552/doc4.xml","form_type":"4"}},{"id":2085681,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-16T02:00:28.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":1514,"price":1.24,"value":1877.36,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These shares were sold in eleven separate transactions, ranging from $1.20 and $1.30 per share."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-061552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122061552/doc4.xml","form_type":"4"}},{"id":2085680,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-16T02:00:28.000Z","date":"2022-12-14","kind":"exercise","acquired":true,"shares":1514,"price":0.415,"value":628.31,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":60514,"source":{"system":"sec-edgar","filing":"0001209191-22-061552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122061552/doc4.xml","form_type":"4"}},{"id":2085679,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-16T02:00:28.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":400,"price":1.35,"value":540.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were sold in three separate transactions, ranging from $1.34 and $1.37 per share."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-061552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122061552/doc4.xml","form_type":"4"}},{"id":2085678,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-16T02:00:28.000Z","date":"2022-12-13","kind":"exercise","acquired":true,"shares":400,"price":0.415,"value":166.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":59400,"source":{"system":"sec-edgar","filing":"0001209191-22-061552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122061552/doc4.xml","form_type":"4"}},{"id":2092664,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-12-09T01:10:34.000Z","date":"2022-12-08","kind":"exercise","acquired":false,"shares":15100,"price":0.415,"value":6266.5,"ownership":{"direct":true},"balance_after":6210,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":21310},"source":{"system":"sec-edgar","filing":"0001209191-22-060425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122060425/doc4.xml","form_type":"4"}},{"id":2092663,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-12-09T01:10:34.000Z","date":"2022-12-06","kind":"exercise","acquired":false,"shares":4816,"price":0.415,"value":1998.64,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F5","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":21310,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":26126},"source":{"system":"sec-edgar","filing":"0001209191-22-060425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122060425/doc4.xml","form_type":"4"}},{"id":2092662,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-09T01:10:34.000Z","date":"2022-12-08","kind":"sale","acquired":false,"shares":15100,"price":1.18,"value":17818.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These shares were sold in six separate transactions, all at $1.18 per share."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-060425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122060425/doc4.xml","form_type":"4"}},{"id":2092661,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-09T01:10:34.000Z","date":"2022-12-08","kind":"exercise","acquired":true,"shares":15100,"price":0.415,"value":6266.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":74100,"source":{"system":"sec-edgar","filing":"0001209191-22-060425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122060425/doc4.xml","form_type":"4"}},{"id":2092660,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-09T01:10:34.000Z","date":"2022-12-06","kind":"sale","acquired":false,"shares":4816,"price":1.21,"value":5827.36,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were sold in four separate transactions, all at $1.21 per share."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-060425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122060425/doc4.xml","form_type":"4"}},{"id":2092659,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-09T01:10:34.000Z","date":"2022-12-06","kind":"exercise","acquired":true,"shares":4816,"price":0.415,"value":1998.64,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":63816,"source":{"system":"sec-edgar","filing":"0001209191-22-060425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122060425/doc4.xml","form_type":"4"}},{"id":2097159,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-12-05T21:46:42.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":1000,"price":0.415,"value":415.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F4","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":26126,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":27126},"source":{"system":"sec-edgar","filing":"0001209191-22-059718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122059718/doc4.xml","form_type":"4"}},{"id":2097158,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-05T21:46:42.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":1000,"price":1.5,"value":1500.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold through multiple transactions, two in all, at prices ranging from $1.50 to $1.51."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-059718","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122059718/doc4.xml","form_type":"4"}},{"id":2097157,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-05T21:46:42.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":1000,"price":0.415,"value":415.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001209191-22-059718","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122059718/doc4.xml","form_type":"4"}},{"id":2103708,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-11-29T02:35:45.000Z","date":"2022-11-25","kind":"exercise","acquired":false,"shares":3000,"price":0.415,"value":1245.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F5","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":27126,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":30126},"source":{"system":"sec-edgar","filing":"0001209191-22-058923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122058923/doc4.xml","form_type":"4"}},{"id":2103707,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-11-29T02:35:45.000Z","date":"2022-11-23","kind":"exercise","acquired":false,"shares":1500,"price":0.415,"value":622.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F5","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":30126,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":31626},"source":{"system":"sec-edgar","filing":"0001209191-22-058923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122058923/doc4.xml","form_type":"4"}},{"id":2103706,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-29T02:35:45.000Z","date":"2022-11-25","kind":"sale","acquired":false,"shares":3000,"price":1.39,"value":4170.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold through multiple transactions, four in all, at prices ranging from $1.35 to $1.41."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-058923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122058923/doc4.xml","form_type":"4"}},{"id":2103705,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-29T02:35:45.000Z","date":"2022-11-25","kind":"exercise","acquired":true,"shares":3000,"price":0.415,"value":1245.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":62000,"source":{"system":"sec-edgar","filing":"0001209191-22-058923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122058923/doc4.xml","form_type":"4"}},{"id":2103704,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-29T02:35:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":1500,"price":1.4,"value":2100.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold through multiple transactions, five in all, at prices ranging from $1.40 to $1.40."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-058923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122058923/doc4.xml","form_type":"4"}},{"id":2103703,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-29T02:35:45.000Z","date":"2022-11-23","kind":"exercise","acquired":true,"shares":1500,"price":0.415,"value":622.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":60500,"source":{"system":"sec-edgar","filing":"0001209191-22-058923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122058923/doc4.xml","form_type":"4"}},{"id":2107548,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-11-23T02:00:18.000Z","date":"2022-11-21","kind":"exercise","acquired":false,"shares":2600,"price":0.415,"value":1079.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F5","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":31626,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":34226},"source":{"system":"sec-edgar","filing":"0001209191-22-058550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122058550/doc4.xml","form_type":"4"}},{"id":2107547,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-11-23T02:00:18.000Z","date":"2022-11-18","kind":"exercise","acquired":false,"shares":10000,"price":0.415,"value":4150.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F5","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":34226,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":44226},"source":{"system":"sec-edgar","filing":"0001209191-22-058550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122058550/doc4.xml","form_type":"4"}},{"id":2107546,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-23T02:00:18.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":2600,"price":1.38,"value":3588.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold through multiple transactions, five in all, at prices ranging from $1.36 to $1.40."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-058550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122058550/doc4.xml","form_type":"4"}},{"id":2107545,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-23T02:00:18.000Z","date":"2022-11-21","kind":"exercise","acquired":true,"shares":2600,"price":0.415,"value":1079.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":61600,"source":{"system":"sec-edgar","filing":"0001209191-22-058550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122058550/doc4.xml","form_type":"4"}},{"id":2107544,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-23T02:00:18.000Z","date":"2022-11-18","kind":"sale","acquired":false,"shares":10000,"price":1.4,"value":14000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released.  In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days.  Typically, this would reopen trading in early-to-mid March, through March 24th.  The next blackout period would begin on March 25th, etc."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold through multiple transactions, eleven in all, at prices ranging from $1.37 to $1.45."}],"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-058550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122058550/doc4.xml","form_type":"4"}},{"id":2107543,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-23T02:00:18.000Z","date":"2022-11-18","kind":"exercise","acquired":true,"shares":10000,"price":0.415,"value":4150.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":69000,"source":{"system":"sec-edgar","filing":"0001209191-22-058550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122058550/doc4.xml","form_type":"4"}},{"id":2113178,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-11-18T02:00:14.000Z","date":"2022-11-17","kind":"exercise","acquired":false,"shares":9400,"price":0.415,"value":3901.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":44226,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":53626},"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113177,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-11-18T02:00:14.000Z","date":"2022-11-16","kind":"exercise","acquired":false,"shares":5,"price":0.415,"value":2.075,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":53626,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":53631},"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113176,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-11-18T02:00:14.000Z","date":"2022-11-15","kind":"exercise","acquired":false,"shares":2300,"price":0.415,"value":954.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":53631,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":55931},"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113175,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2012-11-17","kind":"sale","acquired":false,"shares":1000,"price":1.45,"value":1450.0,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113174,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2012-11-17","kind":"exercise","acquired":true,"shares":1000,"price":0.415,"value":415.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113173,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2012-11-17","kind":"sale","acquired":true,"shares":1100,"price":1.41,"value":1551.0,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113172,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2012-11-17","kind":"exercise","acquired":false,"shares":1100,"price":0.415,"value":456.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":60100,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113171,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2012-11-17","kind":"sale","acquired":false,"shares":5800,"price":1.4,"value":8120.0,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113170,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2012-11-17","kind":"exercise","acquired":true,"shares":5800,"price":0.415,"value":2407.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":64800,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113169,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2012-11-17","kind":"sale","acquired":false,"shares":1000,"price":1.35,"value":1350.0,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113168,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2012-11-17","kind":"exercise","acquired":true,"shares":1000,"price":0.415,"value":415.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113167,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2022-11-17","kind":"sale","acquired":false,"shares":500,"price":1.3,"value":650.0,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113166,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2022-11-17","kind":"exercise","acquired":true,"shares":500,"price":0.415,"value":207.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":59500,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113165,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":5,"price":1.62,"value":8.1,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113164,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2022-11-16","kind":"exercise","acquired":true,"shares":5,"price":0.415,"value":2.075,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":59005,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113163,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":2300,"price":1.8,"value":4140.0,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2113162,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-18T02:00:14.000Z","date":"2022-11-15","kind":"exercise","acquired":true,"shares":2300,"price":0.415,"value":954.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":61300,"source":{"system":"sec-edgar","filing":"0001209191-22-057747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122057747/doc4.xml","form_type":"4"}},{"id":2119009,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-11-15T00:00:24.000Z","date":"2022-11-14","kind":"exercise","acquired":false,"shares":6500,"price":0.415,"value":2697.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":55931,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":62431},"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2119008,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-11-15T00:00:24.000Z","date":"2022-11-11","kind":"exercise","acquired":false,"shares":6586,"price":0.415,"value":2733.19,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":62431,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":69017},"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2119007,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-11-15T00:00:24.000Z","date":"2022-11-10","kind":"exercise","acquired":false,"shares":200,"price":0.415,"value":83.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":69017,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":69217},"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2119006,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-15T00:00:24.000Z","date":"2022-11-14","kind":"sale","acquired":false,"shares":6500,"price":1.9,"value":12350.0,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2119005,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-15T00:00:24.000Z","date":"2022-11-14","kind":"exercise","acquired":true,"shares":6500,"price":0.415,"value":2697.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":65500,"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2119004,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-15T00:00:24.000Z","date":"2022-11-11","kind":"sale","acquired":false,"shares":4986,"price":1.95,"value":9722.7,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2119003,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-15T00:00:24.000Z","date":"2012-11-11","kind":"exercise","acquired":true,"shares":4986,"price":0.415,"value":2069.19,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":63986,"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2119002,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-15T00:00:24.000Z","date":"2022-11-11","kind":"sale","acquired":false,"shares":1400,"price":1.96,"value":2744.0,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2119001,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-15T00:00:24.000Z","date":"2022-11-11","kind":"exercise","acquired":true,"shares":1400,"price":0.415,"value":581.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":60400,"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2119000,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-15T00:00:24.000Z","date":"2022-11-11","kind":"sale","acquired":false,"shares":200,"price":1.97,"value":394.0,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2118999,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-15T00:00:24.000Z","date":"2022-11-11","kind":"exercise","acquired":true,"shares":200,"price":0.415,"value":83.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":59200,"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2118998,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-15T00:00:24.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":200,"price":2.1,"value":420.0,"ownership":{"direct":true},"balance_after":59000,"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2118997,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-11-15T00:00:24.000Z","date":"2022-11-10","kind":"exercise","acquired":true,"shares":200,"price":0.415,"value":83.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These stock options are set to expire on 02/14/2023.  Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume.  His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":59200,"source":{"system":"sec-edgar","filing":"0001209191-22-056830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056830/doc4.xml","form_type":"4"}},{"id":2121626,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-11-10T00:20:50.000Z","date":"2022-11-09","kind":"exercise","acquired":false,"shares":300,"price":0.415,"value":124.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":69217,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":69517},"source":{"system":"sec-edgar","filing":"0001209191-22-056269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056269/doc4.xml","form_type":"4"}},{"id":2121625,"issuer":{"id":7041,"kind":"organization","name":"SOLESENCE, INC."},"owners":[{"id":84222,"kind":"person","name":"JANKOWSKI JESS","position":1,"cik":"0001184478","reported_name":"JANKOWSKI JESS","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock (right to purchase)","published_at":"2022-11-10T00:20:50.000Z","date":"2022-11-08","kind":"exercise","acquired":false,"shares":3000,"price":0.415,"value":1245.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker.  His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors."}],"balance_after":69517,"derivative":{"exercise_price":0.415,"exercise_date":"2014-02-14","expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":72517},"source":{"system":"sec-edgar","filing":"0001209191-22-056269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/883107/000120919122056269/doc4.xml","form_type":"4"}}],"next_cursor":"2022-11-10T00:20:50.000000Z,2121625"}